Compare APLS & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | APLS | FRME |
|---|---|---|
| Founded | 2009 | 1893 |
| Country | United States | United States |
| Employees | N/A | 2120 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 2015 | N/A |
| Metric | APLS | FRME |
|---|---|---|
| Price | $17.28 | $37.93 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $31.65 | ★ $48.33 |
| AVG Volume (30 Days) | ★ 1.9M | 416.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.94% |
| EPS Growth | ★ 112.50 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,003,782,000.00 | N/A |
| Revenue This Year | N/A | $27.77 |
| Revenue Next Year | $18.21 | $5.87 |
| P/E Ratio | $86.38 | ★ $10.90 |
| Revenue Growth | ★ 28.46 | N/A |
| 52 Week Low | $16.10 | $33.29 |
| 52 Week High | $30.48 | $43.22 |
| Indicator | APLS | FRME |
|---|---|---|
| Relative Strength Index (RSI) | 27.60 | 48.88 |
| Support Level | $17.16 | $36.83 |
| Resistance Level | $20.42 | $39.03 |
| Average True Range (ATR) | 0.71 | 0.82 |
| MACD | -0.15 | 0.08 |
| Stochastic Oscillator | 12.23 | 76.76 |
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.